HOLSTEIN AS • 957231373 • Asker

This website uses cookies to enhance the user experience.

||

HOLSTEIN AS

Links

Organization

CEO: SH
Stein Holst Annexstad1944
Chairman of the board: SH
Stein Holst Annexstad1944
Years since formation: 30 years; since Feb 19, 1995
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 6,400; 2 share classes
Total number of shareholders: 5; persons

Financials

Total operating income 2024: 1,603,366; NOK
Annual total result 2024: 986,109; NOK
Total equity 2024: 39,966,991; NOK

Last update: Sep 9, 2025

Management

Management / administration

Name	Role	Shares
SH Stein Holst Annexstad 1944	Managing Director/CEO	26.56 % directly

Board

Name	Role	Shares
SH Stein Holst Annexstad 1944	Chairman	26.56 % directly
LA Linda Aasvangen 1971	Board Member	15.63 % directly
EA Eirik Annexstad 1972	Board Member	15.63 % directly
EJ Ellen Johanne Annexstad 1973	Board Member	15.63 % directly
GM Gerd Myrvang Annexstad 1946	Board Member	26.56 % directly

Others

Name	Role	Shares
R RSM NORGE AS	Auditor	-
F FORMUE ACCOUNTING AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
GM Gerd Myrvang Annexstad 1946	Board Member	26.56 % directly
SH Stein Holst Annexstad 1944	Managing Director/CEO, Chairman	26.56 % directly
EJ Ellen Johanne Annexstad 1973	Board Member	15.63 % directly
LA Linda Aasvangen 1971	Board Member	15.63 % directly
EA Eirik Annexstad 1972	Board Member	15.63 % directly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
GM Gerd Myrvang Annexstad 1946	A-shares	1,700	26.56 %
SH Stein Holst Annexstad 1944	A-shares	1,700	26.56 %
EA Eirik Annexstad 1972	Class B shares	1,000	15.63 %
EJ Ellen Johanne Annexstad 1973	Class B shares	1,000	15.63 %
LA Linda Aasvangen 1971	Class B shares	1,000	15.63 %

Shares owned by the HOLSTEIN AS

Name	Share class	Total number of shares	Share
B BIOMOLEX AS	NO0010162266	2,924	0.35 %
S SERODUS AS	NO0010549801	16,736	0.09 %
N NEXTERA AS	NO0010848534	2,860	0.07 %
G GENTIAN DIAGNOSTICS ASA	NO0010748866	10,000	0.06 %
B BERGENBIO ASA	NO0013251173	7	< 0.01 %
C CIRCIO HOLDING ASA	NO0013033795	1,723	< 0.01 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	1,603,366	5,020,797	727,864	3,278,517
Annual Total Result	986,109	4,445,901	106,134	2,598,309
Total assets	42,157,483	44,199,576	42,058,163	46,997,807
Total liabilities	2,190,492	1,268,694	178,182	1,268,870
Total equity	39,966,991	42,930,881	41,879,981	45,728,937

P&L

Year	2024	2023	2022	2021
Total operating income	1,603,366	5,020,797	727,864	3,278,517
Total operating costs	639,585	574,225	601,069	673,074
Operating result	963,781	4,446,573	126,796	2,605,443
Financial income/costs	22,328	-672	-20,661	-7,134
Profit before tax	986,109	4,445,901	106,134	2,598,309
Total tax & extraordinary income/cost	0	0	0	0
Annual Total Result	986,109	4,445,901	106,134	2,598,309

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	623,518	623,518	623,518	623,518
Total current assets	41,533,965	43,576,058	41,434,645	46,374,289
Total assets	42,157,483	44,199,576	42,058,163	46,997,807
Short term debt	2,190,492	1,268,694	178,182	1,268,870
Long term debt	0	0	0	0
Total liabilities	2,190,492	1,268,694	178,182	1,268,870
Contributed capital	160,000	160,000	160,000	102,400
Retained earnings	39,806,991	42,770,881	41,719,981	45,626,537
Total equity	39,966,991	42,930,881	41,879,981	45,728,937
Total equity and liabilities	42,157,483	44,199,576	42,058,163	46,997,807

Classification

Type of organization

Limited company